RLF — RELIEF THERAPEUTICS Holding SA Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣16.01m
- CH₣7.77m
- CH₣6.08m
Annual cashflow statement for RELIEF THERAPEUTICS Holding SA, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.436 | -7.46 | -7.83 | -34.7 | -50.8 |
| Depreciation | |||||
| Non-Cash Items | -0.021 | 6.7 | -10.5 | 2.19 | 17.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.178 | 0.028 | 0.028 | -5.23 | 5.59 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.618 | -0.728 | -18.3 | -35.7 | -24.1 |
| Capital Expenditures | — | — | — | -13.7 | -0.521 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | 3 | -16.6 | -7.48 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | — | 3 | -30.3 | -8 |
| Financing Cash Flow Items | 0 | — | -0.634 | -2.85 | -0.223 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.748 | 0.6 | 58.2 | 67.7 | 6.42 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.13 | -0.128 | 43 | 1.61 | -25.5 |